Minimal Residual Disease Detection with Urine-derived DNA Is Prognostic for Recurrence-free Survival in Bacillus Calmette-Guérin–unresponsive Non–muscle-invasive Bladder Cancer Treated with Nadofaragene FiradenovecVikram M. Narayan, Colin P. Dinney, Vincent M. Caruso et al.|European Urology Oncology|2024Cited by 18
Urinary minimal residual disease detection predicts recurrence in BCG-unresponsive NIMBC and quantifies molecular response to nadofaragene firadenovec.Vikram M. Narayan, Colin P. Dinney, Côme Tholomier et al.|Journal of Clinical Oncology|2024Cited by 2